Core Viewpoint - Corning Pharmaceutical-B (09966.HK) announced a share buyback program with a maximum amount of HKD 20 million, reflecting the board's confidence in the company's business outlook and intrinsic value [1] Group 1: Share Buyback Announcement - The board of directors resolved to repurchase ordinary shares from the open market on October 12, 2025, under a general authorization approved by shareholders at the annual general meeting on June 12, 2025 [1] - The board believes that the current trading price does not accurately reflect the company's intrinsic value [1] - The buyback is expected to benefit the company and create value for its shareholders [1] Group 2: Financial Position - The board is confident that the company's current financial resources are sufficient to support the proposed share buyback while maintaining a robust financial position [1]
康宁杰瑞制药-B(09966.HK)拟自公开市场购回股份 金额最高为2000万港元